Skip to main navigation

Main navigation

About
EMMs
Platform
Pipeline
Investors & News
Careers
Contact

Corporate Profile
News Releases
Events & Presentations
Stock Information
Financials & Filings
- SEC Filings
- Quarterly Results
Corporate Governance

News Releases

News Releases

Year

Jan 23, 2023

Axcella Announces Regulatory Path to Registration of AXA1125 for Long COVID Fatigue

Read more

Tools

Print

RSS Feeds

Email Alerts

Investor Contact

Search

840 Memorial Drive,
3rd Floor, Cambridge,
MA 02139

O: 857-320-2200
F: 617-441-6243
E: info@axcellatx.com

Footer

About
EMMs
Platform
Pipeline
Investors & News
Contact
Careers

Follow us at:

Copyright © Axcella Therapeutics 2023 All rights reserved. | Terms of Use | Privacy Notice | Axcella and Axcella logo, AXA, EMMPOWER, and EMMPACT are trademarks of Axcella Health Inc. in the U.S. and/or other countries.